Business
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity
LANGHORNE, Pa., March 31, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its fourth quarter and fiscal year 2025 financial results conference call to April 8, 2026 at 4:30 P.M. ET to provide additional time for the Company to provide shareholders
About this update from Celularity Inc.
[{"type":"image","alt":"NEXGEL, INC.","displaySize":"","headline":null,"caption":"NEXGEL, INC.","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":66,"url":"https://media.zenfs.com/en/globenewswire.com/7f0d3c847df57a7d87b54e7056dbb4aa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_MtfgyigCMqHKrZUO1rUcw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMQ--/https://media.zenfs.com/en/globenewswire.com/7f0d3c847df57a7d87b54e7056dbb4aa","width":250,"height":66}},"lazy":false},{"type":"text","content":"LANGHORNE, Pa., March 31, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its fourth quarter and fiscal year 2025 financial results conference call to April 8, 2026 at 4:30 P.M. ET to provide additional time for the Company to provide shareholders with greater detail regarding its previously announced proposed transaction with Celularity Inc.","length":597,"tagName":"p"},{"type":"text","content":"The Company will file its Annual Report on Form 10-K for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission today, March 31, 2026.","length":162,"tagName":"p"},{"type":"text","content":"Fourth Quarter and Full Year 2025 Financial Results Conference Call Details:Date: April 8, 2026Time: 4:30 P.M. ETLive Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)Webcast: Events and Presentations","length":226,"tagName":"p"},{"type":"text","content":"About NEXGEL, Inc.NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.","length":541,"tagName":"p"},{"type":"text","content":"Forward-Looking Statement This press release contains “forward-looking statements” within the meaning of Section 27A of...